 |
 |

THE PRELIMINARY WORK WITH NEOARSPHENAMINE
GEORGE BAEHR, M.D.
Arch Derm Syphilol. 1940;42(2):239-244.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
This meeting has been called in order to review the results of massive dose chemotherapy of syphilis by means of the intravenous drip. The observations to be reported represent an experience with more than 375 male patients with the primary or secondary stage of syphilis.
Rapid sterilization of the body by massive arsenotherapy was the primary aim of Paul Ehrlich. Later, others also attempted to administer amounts of Ehrlich's chemotherapeutic agent comparable to those which are being reported today, but the dangers involved made it necessary to revert to small divided doses given intravenously every five days for one to two years. This prolonged method of therapy results in a loss of 40 to 80 per cent of clinic patients while they are still in the communicable stage of the disease and can continue to transmit their infection to others. The disease has therefore continued to spread annually to several
. . . [Full Text PDF of this Article]
Author Affiliations
NEW YORK
Footnotes
This and the following papers were read at a Conference on Massive Arsenotherapy in Early Syphilis by the Continuous Intravenous Drip Method, called by the Commissioner of Health of the City of New York, Dr. John L. Rice, at the Mount Sinai Hospital, New York, on April 12, 1940.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|